HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Janicot Selected Research

R 306465

11/2007R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Janicot Research Topics

Disease

6Neoplasms (Cancer)
01/2022 - 02/2002
4Carcinoma (Carcinomatosis)
03/2008 - 02/2000
1Neoplasm Metastasis (Metastasis)
09/2017
1Lymphoma (Lymphomas)
11/2007
1Prostatic Neoplasms (Prostate Cancer)
11/2007
1Breast Neoplasms (Breast Cancer)
01/2004

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
10/2006 - 01/2004
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2017
1Antisense OligonucleotidesIBA
09/2017
1Pharmaceutical PreparationsIBA
09/2017
1Catalytic DNA (Deoxyribozyme)IBA
03/2008
1Fluorescein-5-isothiocyanate (FITC)IBA
03/2008
1GoldIBA
03/2008
1Histone Deacetylase InhibitorsIBA
11/2007
1Histone Deacetylases (Histone Deacetylase)IBA
11/2007
1Histones (Histone)IBA
11/2007
1R 306465IBA
11/2007
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2006
1Peptides (Polypeptides)IBA
10/2006
1Immunoglobulin G (IgG)IBA
01/2004
1Monoclonal AntibodiesIBA
01/2004
1DNA (Deoxyribonucleic Acid)IBA
01/2004
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2004
1Tretinoin (Retinoic Acid)FDA LinkGeneric
02/2002
1CyclinsIBA
02/2000

Therapy/Procedure

3Therapeutics
01/2022 - 10/2006
1Drug Therapy (Chemotherapy)
01/2022
1Radiotherapy
01/2022
1Oral Administration
11/2007